Since Purdue
released OxyContin just over 20 years ago, the company has made more than $ 31 billion from it.
Our brain is literally wired to listen to stories,
releasing Oxycontin, the drug of trust.
Not exact matches
In 1996, Purdue Pharmaceuticals brought to market
OxyContin, an «extended
release» version of the opioid oxycodone.
In 2007, three of Purdue's executives pled guilty to felony misbranding at the time of the
release of
OxyContin, and the company paid $ 600 million in fines.
With the
release and aggressive marketing of the long - acting narcotic
OxyContin in 1996, a class of drugs that had largely been reserved for cancer patients was becoming a go - to treatment for conditions such as lower back pain.
But the past two and a half decades have also seen the advent of blockbuster painkillers such as
OxyContin, an extended -
release formulation of oxycodone.